Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local tranexamic acid for prevention of hematoma, swelling, and pain after carpal tunnel release
IRCT20151123025202N32Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of tranexamic acid in carpal tunnel syndrome (CTS), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Postoperative hematoma, Postoperative swelling and 1 more. Started Dec 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on IRCT20151123025202N32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151123025202N32.